Trial intelligence / Profile preview

Ultrasound biomarkers of early response to subcutaneous tocilizumab + methotrexate in early rheumatoid arthritis (TOVERA)

2015-001246-28Phase 4Completed

Sponsor
Cliniques universitaires Saint-Luc
Start
Jul 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of tocilizumab and methotrexate in rheumatoid arthritis (RA), sponsored by Cliniques universitaires Saint-Luc. Started Jul 2015; status: completed.

02

Drugs

tocilizumabmethotrexate
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on 2015-001246-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-001246-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call